Cisplatin and Haemothorax - a phase IV clinical study of FDA data
Summary:
Haemothorax is reported as a side effect among people who take Cisplatin (cisplatin), especially for people who are 60+ old, have been taking the drug for < 1 month also take Etoposide, and have Small cell lung cancer extensive stage.
The phase IV clinical study analyzes which people have Haemothorax when taking Cisplatin. It is created by eHealthMe based on reports of 92,672 people who have side effects when taking Cisplatin from the FDA, and is updated regularly.
What is Cisplatin?
Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.
What is Haemothorax?
Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest)) is found to be associated with 407 drugs and 530 conditions by eHealthMe. Check the latest studies of Haemothorax.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
92,672 people reported to have side effects when taking Cisplatin.
Among them, 35 people (0.04%) have Haemothorax.

Among these 35 people:
How long have people been on Cisplatin when they have Haemothorax? *
- < 1 month: 84.62 %
- 1 - 6 months: 15.38 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the age of people who have Haemothorax when taking Cisplatin? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 6.9 %
- 30-39: 6.9 %
- 40-49: 6.9 %
- 50-59: 10.34 %
- 60+: 68.97 %
What are other drugs people take besides Cisplatin? *
- Etoposide: 13 people, 37.14%
- Dexamethasone: 8 people, 22.86%
- Vepesid: 6 people, 17.14%
- Ondansetron: 4 people, 11.43%
- Pemetrexed: 4 people, 11.43%
- Zofran: 2 people, 5.71%
- Alimta: 2 people, 5.71%
- Cordarone: 2 people, 5.71%
- Cyclophosphamide: 2 people, 5.71%
- Digoxin: 2 people, 5.71%
What are other side effects people have besides Haemothorax? *
- Pleural Effusion (water on the lungs): 13 people, 37.14%
- Thrombocytopenia (decrease of platelets in blood): 8 people, 22.86%
- Empyema (collection of pus in a cavity in the body): 6 people, 17.14%
- Leukopenia (less number of white blood cells in blood): 6 people, 17.14%
- Febrile Neutropenia (fever with reduced white blood cells): 5 people, 14.29%
- Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 14.29%
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 5 people, 14.29%
- Cough: 4 people, 11.43%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 11.43%
- Anaemia (lack of blood): 4 people, 11.43%
What are the existing conditions these people have? *
- Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 6 people, 17.14%
- Pleural Mesothelioma Malignant (cancer of the pleura, or the membrane that lines the lungs): 5 people, 14.29%
- Testis Cancer (testes cancer): 2 people, 5.71%
- Yolk Sac Tumor Site Unspecified: 1 person, 2.86%
- Metastatic Neoplasm (spreadable cancer tumour): 1 person, 2.86%
- Carcinoma (cancer): 1 person, 2.86%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 2.86%
- Lung Adenocarcinoma Metastatic (a form of non-small cell lung cancer spreads to other part): 1 person, 2.86%
- Malignant Hydatidiform Mole (a cancer tumour of trophoblast cells): 1 person, 2.86%
- Metastatic Choriocarcinoma (cancer of embryo covering cells can spread to other part): 1 person, 2.86%
* Approximation only. Some reports may have incomplete information.
Do you take Cisplatin and have Haemothorax?
- Check whether Haemothorax is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cisplatin:
- Cisplatin (92,837 reports)
Haemothorax treatments and more:
- Haemothorax (3,670 reports)
How severe was Haemothorax and when was it recovered:
Expand to all the drugs that have ingredients of cisplatin:
Sub-studies by age:
0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cisplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Haemothorax:
- Haemothorax (407 drugs)
Browse all the conditions that are associated with Haemothorax:
- Haemothorax (530 conditions)
Related publications that referenced our studies
- Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
- Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on cisplatin (the active ingredients of Cisplatin) and Cisplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Gemcitabine Hydrochloride cause Arthritis? - 2 seconds ago
- Could Tyvaso cause Jaw Disorder? - 5 seconds ago
- Could Cholestyramine cause Drug Level Increased? - 5 seconds ago
- Could Vitamin B2 cause Heart Palpitations? - 10 seconds ago
- Could Vitamin B1 cause Diarrhea Aggravated? - 10 seconds ago
- Could Metolazone cause Asthma Aggravated? - 19 seconds ago
- Drug interactions of Generlac and Prevacid - 23 seconds ago
- Could Pregabalin cause Urinary Tract Obstruction? - 31 seconds ago
- Could Methotrexate cause Superinfection? - 32 seconds ago
- Could Methotrexate cause Necrotising Fasciitis Streptococcal? - 41 seconds ago